These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 23458779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus.
    Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY.
    QJM; 2006 Jan; 99(1):37-47. PubMed ID: 16371405
    [Abstract] [Full Text] [Related]

  • 3. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP, Catalan Pellet S, Pappalardo C, Cruzat VC, Spinetto MA, Dubinsky D, Tiraboschi IN, Laborde HA, Nasswetter G.
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [Abstract] [Full Text] [Related]

  • 4. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
    Hu SC, Lin CL, Lu YW, Chen GS, Yu HS, Wu CS, Lan CC.
    Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study.
    Merayo-Chalico J, Demichelis-Gómez R, Rajme-López S, Aparicio-Vera L, Barrera-Vargas A, Alcocer-Varela J, Gómez-Martín D.
    Thromb Res; 2014 Nov; 134(5):1020-7. PubMed ID: 25257921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
    Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonfá E.
    J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus.
    Mok MY, Ip WK, Lau CS, Lo Y, Wong WH, Lau YL.
    J Rheumatol; 2007 Jun; 34(6):1270-6. PubMed ID: 17552055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
    Liao YN, Liu CS, Tsai TR, Hung YC, Chang SJ, Lin HL, Chen YC, Lai HM, Yu SF, Chen CJ.
    Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of the association of leukopenia and severe infection in patients with systemic lupus erythematosus.
    Lertchaisataporn K, Kasitanon N, Wangkaew S, Pantana S, Sukitawut W, Louthrenoo W.
    J Clin Rheumatol; 2013 Apr; 19(3):115-20. PubMed ID: 23519174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.